Topics

MIT's DIAL system offers precise, adjustable control over protein expression in synthetic gene circuits to enhance uniform cell reprogramming and enable tailored therapies.

KAIST researchers create a method to find and restore key genes in disrupted cellular networks, offering potential for cancer treatments, drug development, and personalized medicine through precise control.

This breakthrough uses a protein from living cells as a qubit to sense tiny changes in biology, potentially revolutionizing how we study cells and advance quantum technology.

Researchers engineer a system where bacteria carry viruses into tumors, evading immune defenses to kill cancer cells while preventing spread to healthy tissue.

New technology creates tiny blood vessels to study drug effects and organ interactions

A new report warns AI is lowering barriers to creating bioweapons. Experts simulating a pandemic with 60M deaths urge global action on this emerging security threat.

This new method brings lab-based protein evolution closer to natural biological processes by incorporating timing and switching behaviors.

Synthetic biologists have completed the construction of the final chromosome in the first synthetic yeast genome.